BIOMAT Database Logo BIOMAT Database Logo

HIV seropositivity in i.v. drug users in Ohio. 1988

P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin

UI MeSH Term Description Entries
D008297 Male Males
D009820 Ohio State bounded on the north by Michigan and Lake Erie, on the east by Ohio River and Pennsylvania, on the south by Ohio River, and on the west by Indiana.
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Predictors of HIV seropositivity in Newark and Jersey City i.v. drug users not currently enrolled in treatment.
January 1990, NIDA research monograph,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Prevention of HIV infection in i.v. drug users.
January 1988, Image--the journal of nursing scholarship,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
[Malaria in intravenous drug users associated with HIV seropositivity].
February 1991, Revista de saude publica,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
HIV risk behaviors and HIV seropositivity among young injection drug users.
April 1993, Puerto Rico health sciences journal,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
February 2016, The Kaohsiung journal of medical sciences,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
HIV-1 symptoms similar in i.v. drug users, gays/bisexuals.
November 1992, Today's OR nurse,
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Regional variations in HIV antibody seropositivity in British intravenous drug users.
June 1986, Lancet (London, England),
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Risk factors and HIV seropositivity among injecting drug users in Bangkok.
December 1991, AIDS (London, England),
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
HIV seropositivity in community-recruited and drug treatment samples of injecting drug users.
January 1992, AIDS (London, England),
P J Seligman, and R J Campbell, and G P Keeler, and T J Halpin
Factors associated with HIV seropositivity in European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.
November 1993, AIDS (London, England),
Copied contents to your clipboard!